The Heart Failure Congress is renowned worldwide for its comprehensive coverage of everything related to heart failure, from prevention to treatment. Organised by the Heart Failure Association of the ESC, this annual meeting is dedicated to advancing knowledge, improving patient care, and fostering collaboration in the field.

This year's edition, held both in Lisbon and online, promises an exceptional program curated by esteemed experts in the field. From insightful sessions to groundbreaking research presented in the Late-Breaking Science segment, there's something for everyone keen to delve into the latest advancements in heart failure management.

The Richmond team will be joining for an enriching experience filled with discovery, learning, and networking opportunities. 

To find out more, please visit https://www.escardio.org/Congresses-Events/Heart-Failure 

Latest news

Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director

July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
Read more

Upcoming Event

ESC Congress 2026

28 - 31 August 2026
Richmond Pharmacology is pleased to attend the ESC Congress 2026 in Munich, Germany, on 28 - 31 August 2026.
View event